Stem cell-derived tissue- associated regulatory T cells ameliorate the development of autoimmune arthritis by unknown
POSTER PRESENTATION Open Access
Stem cell-derived tissue- associated regulatory
T cells ameliorate the development of
autoimmune arthritis
Mohammad Haque*, Kristin Fino, Jianxun Song
From 30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2015)
National Harbor, MD, USA. 4-8 November 2015
Background
Embryonic stem cells have the ability to grow indefinitely
while maintaining pluripotency. Under the right circum-
stance, pluripotent stem cells (PSC) can produce almost
all of the cells in the body including regulatory T cell
(Tregs). Tregs are essential for normal immune surveillance
systems, and their dysfunction leads to the development of
diseases, such as autoimmune disorders. PSC are a poten-
tial renewable source of healthy Tregs, which could treat a
wide array of autoimmune disorders. However, the right
circumstances for the development of antigen (Ag)-
specific Tregs from PSC (i.e., PSC-Tregs) has not been well
defined. So the purpose of this study is to develop antigen-
specific Tregs from pluripotent stem cells for treatment of
Ag-induced arthritis (AIA) in mice.
Methods
In this study mouse iPS cells were transduced with FoxP3
and ovalbumin-specific TCR (OTII). iPS cells were driven
toward T lymphocyte lineage by co-culture on OP9 cells
expressing delta-like (DL1), a Notch ligand. The combina-
tion of Notch signaling, FoxP3, and TCR drove iPS cell to
differentiation into Ag-specific Tregs. In vitro generated
Tregs were adoptively transferred into AIA mice.
Results
Our results showed that TCR transduced iPS cells differ-
entiated into Tregs and express CD3, TCRb, CD4, CD8,
CD25, CTLA4 in vitro. Adoptive transfer of such Tregs
dramatically suppressed autoimmunity in a well-
established AIA model, including the inflammation, joint
destruction, cartilage prostaglandin depletion, osteoclast
activity, and Th17 production.
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Figure 1 Model of the experiment.
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Figure 2 Retroviral transduction result.
Figure 3 Arthritis development was reduced in adoptively transferred mice.
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Figure 4 Joint destruction.
Figure 5 Adoptively transferred cells are functional.
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Figure 6 Adoptively transfer cells are in persistence in vivo.
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